Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 9, 2016, Pages

  Knight Madden, Jennifer M ^a   Hambleton, Ian R ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

ACUTE CHEST SYNDROME; DRUG USE; EMBASE; HUMAN; INTERVENTION STUDY; MEDLINE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW;

EID: 84988850851     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003733.pub4     Document Type: Review

References (31)

1. Al Hajeri A, Serjeant GR, Fedorowicz Z. Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006957]
2. Armitage P, Berry G. Further analysis of categorical data. Kappa measure of agreement. Statistical methods in medical research. 3rd Edition. Oxford: Blackwell Press, 1994:443-5.
3. Barnes PJ. Airway pharmacology. In: Murray JF, Nadel JA editor(s). Textbook of Respiratory Medicine. 3rd Edition. Philadelphia: WB Saunders, 2000:267-96.
4. Bayoumi RA. Does the mechanism of protection from falciparum malaria by red cell genetic disorders involve a switch to a balanced TH1/TH2 cytokine production mode?. Medical Hypotheses 1997;48(1):11-7.
5. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994;84(2):643-9.
6. Corso M, Ravindranath TM. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration. Pediatric Emergency Care 2005;21(2):99-101.
7. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology. 2002;31(1):140-9.
8. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995;86(2):776-83.
9. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. Journal of Clinical Pathology 1991;44(6):459-63.
10. Handelsman E, Voulalas D. Albuterol inhalations in acute chest syndrome [letter]. American Journal of Diseases of Children 1991;145(6):603-4.
11. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.
12. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
13. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011] Available from www.cochrane-handbook.org. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration.
14. Knight J, Murphy TM, Browning I. The lung in sickle cell disease. Pediatric Pulmonology 1999;28(3):205-16.
15. Knight-Madden JM, Forrester TS, Lewis NA, Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 2005;60(3):206-10.
16. Koumbourlis AC, Zar HJ, Hurlet-Jensen A, Goldberg MR. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. Journal of Pediatrics 2001;138(2):188-92.
17. Leong MA, Dampier C, Varlotta L, Allen JL. Airway hyperreactivity in children with sickle cell disease. Journal of Pediatrics 1997;131(2):278-83.
18. Murray JF, Nadel JA, Murray R, Mason RJ. Airway Pharmacology. Textbook of Respiratory Medicine. 3rd Edition. Philadelphia: W B Saunders, 2000:267-96.
19. Perin RJ, McGeady SJ, Travis SF, Mansmann HC Jr. Sickle cell disease and bronchial asthma. Annals of Allergy 1983;50(5):320-2.
20. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine 1994;330(23):1639-44.
21. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
22. Savoy LB, Lim JD, Sarnaik SA, Jones DC. Prevalence of atopy in a sickle-cell anemia population. Annals of Allergy 1988;61(2):129-32.
23. Sofowora EO. Bronchial asthma in the tropics. A study of 250 Nigerian patients. East African Medical Journal 1970;47(8):434-9.
24. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. British Medical Journal (Clinical Research Edition) 1982;285(6342):633-5.
25. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine 2000;342(25):1855-65.
26. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization 2001;79(8):704-12.
27. World Health Organisation. Joint WHO/TIF Meeting on the Control of Haemoglobinopathies. Report of the VIIth Meeting of the WHO Working Group on the Control of Hereditary Anaemias, Nicosia, Cyprus. (unpublished document WHO/HDP/TIF/HA/93.1). Geneva: WHO, 1994.
28. Wierenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 2001;357(9257):680-3.
29. Knight-Madden JM, Hambleton IR. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003733]
30. Knight-Madden JM, Hambleton IR. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD003733.pub2]
31. Knight-Madden JM, Hambleton IR. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD003733.pub3]